Ovulation induction : update '98 : the proceedings of the 2nd World Conference on Ovulation Induction, Bologna, Italy, 12-13 September 1997
著者
書誌事項
Ovulation induction : update '98 : the proceedings of the 2nd World Conference on Ovulation Induction, Bologna, Italy, 12-13 September 1997
Parthenon Pub. Group, 1998
- タイトル別名
-
Ovulation induction : update '98
大学図書館所蔵 全1件
注記
Includes bibliographical references and index
内容説明・目次
内容説明
This is a major clinical reference work on all aspects of ovulation induction, featuring 31 chapters by leading authorities in assisted reproduction and related fields. It contains especially detailed coverage of Polycystic Ovarian Syndrome and Ovarian Hyperstimulation Syndrome along with every other topic of current importance in ovulation induction research and practice. Includes bibliographic references and index.
目次
Relative roles of gonadotropins and intraovarian steroids in the outcome of ovulation induction. Role of other non-gonadotropic hormones in ovulation induction. Role of body weight and insulin in ovulation induction. Role of age and ovary status inovulation induction. Disorders of folliculogenesis in PCO. Regular-dose gonadotropins in PCO: outcome and complications. Pulsatile GnRH in hypogonadotropic hypogonadism. Pulsatile GnRH in PCO. Low-dose FSH: endocrine aspects and clinical results.Predictors of follicle development in gonadotrophin: induction of ovulation using a decremental dose regimen. Characteristics of long regimens. Characteristics of short regimens. Characteristics of very short regimens. Risks of GnRH agonist administrationin early pregnancy. GnRH antagonists: an overview. Endocrine features of combined gonadotropin and GnRH antagonist ovulation induction. Current status of GnRH antagonists in assisted reproduction: single dose applications. Recombinant FSH: results inassisted reproduction. Recombinant FSH and GnRH antagonist: role of antagonist dose. Recombinant LH: induction of the midcycle surge. Supplementation with recombinant LH to reduce multiple folliculogenesis and ovarian hyperstimulation. Pathogenesis ofOvarian Hyperstimulation Syndrome. Prevention of OHS with preovulatory GnRH or GnRH agonists: does it work Prevention and management of OHS with albumin. hMG versus FSH: is there any difference Clinical outcome of ovulation induction: highly purifiedFSH versus hMG. Ovulation induction monitoring: is ultrasound alone sufficient Fetal reduction. Exogenous gonadotropins and ovarian and breast cancer. Ovulation induction update 1997: feedback from the audience. Index.
「Nielsen BookData」 より